Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy
Abstract This report presents the case of a 42‐year‐old Japanese woman with recurrent hormone receptor–positive breast cancer who developed eosinophilic pneumonia (EP) during treatment with abemaciclib combined with endocrine therapy. Seven years after a radical surgery and definite diagnosis of Sta...
Main Authors: | Hiroaki Ogata, Chinami Koga, Toyoshi Yanagihara, Yuki Moriuchi, Aimi Enokizu‐Ogawa, Akiko Ishimatsu, Junji Otsuka, Kazuhito Taguchi, Atsushi Moriwaki, Eriko Tokunaga, Makoto Yoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Respirology Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/rcr2.1320 |
Similar Items
-
Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole: a case report and literature review
by: Nuno Rodrigues Alves, et al.
Published: (2024-01-01) -
Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas
by: Muh-Lii Liang, et al.
Published: (2020-12-01) -
Development of a SPE-LC-MS Method for the Quantitation of Palbociclib and Abemaciclib in Human Plasma
by: Daniela Maria Calucică, et al.
Published: (2022-12-01) -
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib
by: Natansh D. Modi, et al.
Published: (2021-08-01) -
Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story
by: Vittorio Gebbia
Published: (2023-04-01)